Ascentage Pharma Group International (AAPG) Total Liabilities (2023 - 2025)

Ascentage Pharma Group International (AAPG) has reported Total Liabilities for 3 consecutive years, with $370.7 million the latest figure, recorded in Q4 2025.

• Quarterly Total Liabilities rose 13.62% year-over-year to $370.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $370.7 million (up 13.62% YoY) and the FY2025 annual result came in at $376.0 million, up 17.1% from the prior year.
• Total Liabilities declined to $370.7 million in Q4 2025 per AAPG's latest filing, from $425.2 million in the prior quarter.
• Over the last five years, Total Liabilities for AAPG reached as high as $425.2 million in Q2 2025 and fell as low as $326.3 million in Q4 2024.
• A 3-year average of $364.9 million and a median of $354.1 million in 2023 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2024 — Total Liabilities declined 3.32% — and 2025, when it gained 13.62%.
• Year by year, Total Liabilities stood at $337.5 million in 2023, then declined by 3.32% to $326.3 million in 2024, then rose by 13.62% to $370.7 million in 2025.
• According to Business Quant data, Total Liabilities over the past three periods registered $370.7 million, $425.2 million, and $326.3 million for Q4 2025, Q2 2025, and Q4 2024 respectively.